Oxford Bioscience Partners Overview
- Investor Type
-
Venture Capital
- Status
-
Inactive
- Investments
-
225
- Portfolio
-
5
- Exits
-
128
Oxford Bioscience Partners General Information
Company Description
Oxford Bioscience Partners was an early-stage venture capital investment firm that was based in Boston, Massachusetts. The firm invested in life sciences and healthcare sectors with a focus on technology, medical devices, instruments and systems, and therapeutics companies. Oxford invested in pre-commercial stage businesses that solve problems throughout the international life science market.
Business Details
Website
www.oxbio.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- P.O. Box 207
- 12 Giles Place
- Mansfield, MA 02048
- United States
Oxford Bioscience Partners Investments (225)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Yolia Health | 01-Jan-2017 | Later Stage VC | 000 | Therapeutic Devices | Generating Revenue | 00000000 000 |
GreenLight Biosciences | 15-Jun-2015 | 00000 00000 | 0000 | Biotechnology | Generating Revenue/Not Profitable | 00000000 000 |
CardioFocus | 05-Jan-2015 | 00000 00000 | 000.00 | Surgical Devices | Generating Revenue | |
eSionic | 19-Nov-2014 | 00000 00000 | Energy Storage | Out of Business | 0000000 0000 | |
Phyto (Food Products) | 28-Apr-2014 | 00000 00000 | Food Products | Generating Revenue | ||
Affinium Pharmaceuticals | 30-Aug-2013 | 00000 00000 | 000.00 | Pharmaceuticals | Out of Business | 0000 000000 |
CJ Bioscience | 01-Aug-2013 | 00000 00000 | 00.000 | Biotechnology | Generating Revenue | |
Dicerna Pharmaceuticals | 01-Aug-2013 | 00000 00000 | 0000 | Pharmaceuticals | Generating Revenue | 0000000 0000 |
Luca Technologies | 17-Jan-2013 | Later Stage VC | 000 | Energy Production | Out of Business | 0000000 0000 |
PharmAbcine | 11-Jun-2012 | Early Stage VC | 00.00 | Biotechnology | Generating Revenue |
Oxford Bioscience Partners Exits (128)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
abiliti | 02-Sep-2022 | Out of Business | |
GreenLight Biosciences | 04-Feb-2022 | 0000000 0000 | 00000 |
Adastra Pharmaceuticals | 07-Sep-2021 | 000000000000 | |
Melinta Therapeutics | 27-Dec-2019 | 0000000000: | |
Mitralign | 12-Mar-2019 | 000000000000 | |
PharmAbcine | 21-Nov-2018 | 000 | |
Ensemble Therapeutics | 22-Nov-2017 | 000 00 00000 | |
Melinta Therapeutics | 03-Nov-2017 | 0000000 0000 | |
Selventa | 30-Jun-2017 | Out of Business | |
Glori Energy | 24-Mar-2017 | Merger/Acquisition |
Oxford Bioscience Partners Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
Oxford Bioscience Partners Investments by Industry, Year, and Region
Oxford Bioscience Partners Management, Team & Partners (27)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Daniel Cole | Venture Partner | 00 | 0 | 0 | Boston, MA |
Oxford Bioscience Partners FAQs
-
What is Oxford Bioscience Partners?
Oxford Bioscience Partners was an early-stage venture capital investment firm that was based in Boston, Massachusetts.
-
When was Oxford Bioscience Partners founded?
Oxford Bioscience Partners was founded in 1992.
-
Who is the founder of Oxford Bioscience Partners?
Cornelius Ryan is the founder of Oxford Bioscience Partners.
-
Where is Oxford Bioscience Partners headquartered?
Oxford Bioscience Partners is headquartered in Mansfield, MA.
-
How many investments has Oxford Bioscience Partners made?
Oxford Bioscience Partners has made 225 investments.
-
What has Oxford Bioscience Partners invested in?
Oxford Bioscience Partners has made numerous investments in companies like Yolia Health, GreenLight Biosciences, and CardioFocus within the Therapeutic Devices, Biotechnology, and Surgical Devices industries.
-
What has Oxford Bioscience Partners invested in recently?
Oxford Bioscience Partners's latest investment was on 01-Jan-2017 in Yolia Health, a company within the Therapeutic Devices industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »